Showing results (1-10 of 394) with videos related to
Sort By:
Pageof 40
Blood Cancer Discovery|December 12, 2025
Overcoming BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia by Targeting PKCβBilly Michael Chelliah Jebaraj, Stephan StilgenbauerBritish Journal of Haematology|March 12, 2026
Short and complex-Telomeres and genomes in CLLBilly Michael Chelliah Jebaraj, Stephan StilgenbauerFrontiers in Oncology|February 1, 2021
Telomere Dysfunction in Chronic Lymphocytic LeukemiaBilly Michael Chelliah Jebaraj, Stephan StilgenbauerRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Venetoclax: Targeting BCL2 in Hematological CancersAnnika Scheffold, Billy Michael Chelliah Jebaraj, Stephan StilgenbauerMethods in Molecular Biology (Clifton, N.J.)|March 3, 2025
Quantification of Telomere Length in Peripheral Blood Mononuclear Cells Using Quantitative Polymerase Chain ReactionBilly Michael Chelliah JebarajLeukemia & Lymphoma|October 24, 2012
BRAF mutations in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Dirk Kienle, Andreas Bühler, et al.Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.Leukemia & Lymphoma|October 25, 2017
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcomeDaniela Steinbrecher, Billy Michael Chelliah Jebaraj, Christof Schneider, et al.Haematologica|March 18, 2021
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patientsJohannes Bloehdorn, Julia Krzykalla, Karlheinz Holzmann, et al.Acta Neuropathologica Communications|August 24, 2016
Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse modelAnnika Scheffold, Inge R Holtman, Sandra Dieni, et al.Pageof 40